ag娱乐平台出租



Match Document Document Title
10663470 Immunoassay of S-adenosylmethionine in personalized medicine and health or cancer evaluation  
The invention provides a method of detecting the presence or absence of a disease in a patient wherein said disease is accompanied by deficient levels of S-adenosylmethionine comprising:...
10663469 ag娱乐平台出租Method for using information on complex biomarker group to diagnose lung cancer in a subject and diagnostic kit and computing system using the same  
A method for diagnosing lung cancer in a subject by using a complex biomarker group is provided. The method includes steps of: (a) a computing system (1) acquiring a model M by using expression...
10663465 Disruption of EGFR-SAR1 interaction for cancer treatment  
The present invention relates to the discovery that delivery of EGFR to cell surface requires EGFR-SAR1A binding. Thus, the invention provides a method for identifying inhibitors of EGFR-SAR1A...
10663464 ag娱乐平台出租CEACAM1 based point-of-care cancer diagnostic  
The present technology regards the utilization of CEACAM1 as a biomarker for cancer. In particular the present invention regards the detection and measurement of soluble CEACAM1 levels for the...
10662478 Serine proteases as biomarkers for ovarian cancer  
The described invention provides methods for detecting, diagnosing and treating low-grade ovarian cancer and stage I ovarian cancer by comparing results from serum and ovarian tissue samples with...
10662441 Viral vector targeting cancer stem cells  
[Problem] To provide a novel and effective method for treating cancer, method for preventing cancer, and method for suppressing metastasis by targeting cancer stem cells, the methods being capable...
10662247 Compositions and methods of use for augmented immune response and cancer therapy  
The present invention provides antibody compositions, including, e.g., antibodies, engineered antibodies and antibody fragments that bind to a tumor necrosis factor receptor superfamily member...
10662233 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10661095 Photodynamic therapy for use in treating cancer  
Disclosed is the use of copper cysteamine nanoparticles for use in photodynamic cancer therapy. The disclosed methods of treatment utilize microwave radiation as a means for activating the copper...
10660955 Cancer methods  
A method of treating a patient having a cancer in which HER2, HER4, FGFR1, EPHA2 and/or FGFR3 is upregulated and/or in which HER2, HER4, FGFR1, EPHA2 and/or FGFR3 mediated-signaling is...
10660954 Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer  
The novel synergistic combination of immune checkpoint blockade and hematopoietic stem cell transplantation and/or hematopoietic stem cell mobilization yield synergistic effects in disease therapy.
10660931 Herbo-mineral formulation for the treatment of cancer and method of preparation thereof  
Herbo-mineral formulation for the treatment of cancer and method of preparation are disclosed herein. The disclosed formulation includes a combination of herb and mineral components that...
10660912 Combination therapy for cancer  
Disclosed is a combination of gemcitabine-[phenyl-benzoxy-L-alaninyl)]-phosphate (chemical name: 2′-Deoxy-2′,2′-difluoro-D-cytidine-5′-O-[phenyl (benzoxy-L-alaninyl)]phosphate) (NUC-1031) and a...
10660909 Method for treating cancer using chemokine antagonists  
What is described is a method for treating cancer in a patient in need of such treatment through the use of an antagonist to CXCR1 and/or CXCR2 receptors by administering a therapeutically...
10660889 Compounds for treatment of cancer  
The present invention relates to compounds as inhibitor of WNT signal transduction pathway, as well as a composition comprising the same. Further, the present invention relates to the use of the...
10660861 Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy  
Currently available glutaminase inhibitors are generally poorly soluble, metabolically unstable, and/or require high doses, which together reduce their efficacy and therapeutic index. These can be...
10660565 Device, method and system for implementing a physical area network for cancer immunotherapy  
A physical area network described herein enables significantly improved health monitoring and treatment by utilizing internal (in-body) mechanisms and information and external mechanisms and...
10657644 ag娱乐平台出租Breast cancer detection  
A hybrid detection model may be used for breast cancer detection. A system can identify a region of interest on a received mammogram. The region of interest may have a particular level of grey at...
10656155 Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis  
Biomarkers of pancreatic cancer are described, as well as methods using these compounds for detecting pancreatic cancer. The methods can be used to diagnose a patient's health state, or change in...
10656154 Methods for detecting an amount of complement factor B protein and carbohydrate antigen 19-9 protein, and methods for diagnosing and treating pancreatic cancer using the same  
The present application relates to a kit for diagnosing pancreatic cancer, a method for providing information for diagnosing pancreatic cancer using the kit, and a method for diagnosing pancreatic...
10655187 Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof  
The present invention relates to a gene for predicting or diagnosing the prognosis of early-stage breast cancer and to a use thereof, and more specifically relates to a genetic marker for...
10655186 Point mutations in TRK inhibitor-resistant cancer and methods relating to the same  
Provided herein are methods of treating a subject having a cancer, methods of selecting a treatment for a subject having a cancer, methods of selecting a subject having a cancer for a treatment...
10655184 Methods and compositions involving miR-135b for distinguishing pancreatic cancer from benign pancreatic disease  
Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.
10655130 Modulation of breast cancer growth by modulation of XBP1 activity  
Described herein is a previously unknown function of XBP1 in triple-negative breast cancer (TNBC). It is shown that XBP1 is preferentially spliced and activated in TNBC, and that deletion of XBP1...
10655121 Galvanotaxis assay for quantitative assessment of metastatic potential of cancer cells  
A system for accelerating and/or inhibiting the migration of cells by applying a time-varying magnetic field to induce eddy currents that promote electrotaxis (galvanotaxis) of cells without the...
10654934 Use of chimeric antigen receptor modified cells to treat cancer  
The present disclosure relates to compositions and methods for compositions, methods, and kits for treating cancer using chimeric antigen receptor (CAR) modified cells. Some embodiments of the...
10654904 Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10654903 Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers  
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...
10654889 Peptide having anticancer activity, and pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer comprising the same as active ingredient  
The present invention relates to a peptide having anticancer activity, and a pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and...
10654884 Purine derivatives as CD73 inhibitors for the treatment of cancer  
Provided are novel purine nucleoside/nucleotide analogues compounds, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are inhibitors of CD73 and are useful...
10654877 Dioxolane analogues of uridine for the treatment of cancer  
The invention provides compounds of the formula: R1 is OR11, or NR5R5′;R2 is H or F;R5 is H, C1-C6alkyl, OH, C(═O)R6, O(C═O)R6 or O(C═O)OR6;R5′ is H or C1-C6alkyl;R6 is C1-C6alkyl or...
10654811 Heterocyclic compounds for cancer imaging and treatment and methods for their use  
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, X, n1, n2, and n3 are as defined...
10653751 ag娱乐平台出租Methods of treating cancer metastasis by using interleukin-10  
Methods of treating subjects having a disease or disorder responsive to IL-10, including methods of administration and dosing regimens associated therewith, are provided.
10653735 Uses of Mesembryanthemum crystallinum L. callus extract in delaying skin cell aging, nursing skin, treating and preventing skin cancer  
Use of Mesembryanthemum crystallinum L. callus extract in the manufacture of a medicament or a skin care product, wherein the medicament or skin care product is for at least one of delaying skin...
10653705 Applications for estrone in preparing anti-ovarian cancer and/or breast cancer products  
This invention discloses uses for estrone in preparing anti-ovarian cancer and/or breast cancer products. This invention provides uses for estrone in the preparation of products to treat ovarian...
10653651 Kit for treating cancer with low molecular weight components of aurin tricarboxylic acid complex  
A method of preventing and/or treating cancer in a subject is provided. The method includes administering to the subject a composition comprising an effective amount of an active agent selected...
10653638 Pimarane diterpenoids for use in cancer treatment  
A pimarane diterpenoid, having the following structure: or a tautomer thereof in which R1 and R2 are independently selected from —H, C1-10 alkyl, C1-10 alkoxy, C1-10 alkenyl, C1-10 alkenoxy, —OH,...
10653357 Device, method and system for implementing a physical area network for cancer immunotherapy  
A physical area network described herein enables significantly improved health monitoring and treatment by utilizing internal (in-body) mechanisms and information and external mechanisms and...
10648983 Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies  
A method of identifying a subject having cancer who is likely to be responsive to a treatment compound, comprising administering the treatment compound to the subject having the cancer; obtaining...
10648040 Immune gene signatures in treating breast cancer  
This invention relates to methods for treating subjects with breast cancer, based on tumor expression levels of chemokines.
10648039 Use of methylation sites in Y chromosome as prostate cancer diagnosis marker  
Disclosed is a use of methylation sites as a disease diagnosis marker, in particular relating to a use of methylation sites in a Y chromosome as a prostate cancer diagnosis marker. More...
10648036 Receptor gene for peptide cancer antigen-specific T cell  
The invention provides the nucleotide sequence and amino acid sequence of the CDR3 domain of the T cell receptor (TCR) gene of a WT1-specific cytotoxic T cell (CTL) against WT1 protein. Also...
10648035 Methods and compositions for diagnosing and treating gastric cancer  
The present invention relates to the field of gastric cancer. More specifically, the present invention provides methods and compositions for diagnosing and treating gastric cancer. In a specific...
10647707 Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer  
Provided herein are benzimidazole derivatives, for example, of Formula I, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or...
10647686 Substituted pyrimidines for preventing or treating cancer and inflammatory diseases  
The present invention relates to compounds represented by Formula 1 or a pharmaceutically acceptable salt thereof,wherein:R1 is chloro or methyl;R2 is hydrogen or chloro;R3 is hydrogen, fluoro,...
10646567 Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors  
The present invention describes combination treatment comprising a PD-1 axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where...
10646532 ag娱乐平台出租Method for preparing water extract of ashwagandha leaves which has enhanced anti-cancer activity utilizing cyclodextrin, and pharmaceutical composition containing ashwagandha leaves  
It is an object of the present invention to provide a method for preparing a water extract of ashwagandha, which comprises increasing the amounts of withanone and withaferin A contained as active...
10646521 ag娱乐平台出租Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment  
The present invention provides methods for determining if a patient is likely to benefit from a cancer treatment, by determining if said patient has a gut dysbiosis with an over representation of...
10646479 Use of N-(4-iodobenzoylamino)-5-ethyl-1,2,3,6-tetrahydropyridine as a treatment for cancer  
Disclosed herein is the use of N-(4-iodobenzoylamino)-5-ethyl-1,2,3,6-tetra-hydropyridine as a treatment for cancer.
10646474 Glucocorticoid receptor modulators to treat pancreatic cancer  
Methods and compositions for treating a subject hosting a non-ACTH-secreting pancreatic tumor are disclosed. The methods include administering to the subject a chemotherapeutic agent and a...

华夏彩票注册 盛源彩票投注 湖北快3走势 彩票高賠率好平台 彩票平台刷流水赚钱 吉林快3走势 北京28预测 聚发彩票注册 新疆喜乐彩走势图 快乐时时彩